EyePoint Pharmaceuticals
EYPT
EYPT
138 hedge funds and large institutions have $476M invested in EyePoint Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 49 increasing their positions, 47 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $508M → $476M (-$32.1M)
9% less funds holding
Funds holding: 151 → 138 (-13)
38% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 34
Holders
138
Holding in Top 10
3
Calls
$5.09M
Puts
$2.57M
Top Buyers
| 1 | +$13.1M | |
| 2 | +$10.9M | |
| 3 | +$7.99M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$3.69M |
| 5 |
Goldman Sachs
New York
|
+$3.39M |
Top Sellers
| 1 | -$7.64M | |
| 2 | -$7.17M | |
| 3 | -$6.41M | |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$5.89M |
| 5 |
Millennium Management
New York
|
-$5.05M |